<--- Back to Details
First PageDocument Content
Adjuvant therapy / Non-small-cell lung carcinoma / Chemotherapy / Oncology / Raja M. Flores / Nicholas J. Vogelzang / Medicine / Cancer treatments / Lung cancer
Date: 2013-01-18 15:35:16
Adjuvant therapy
Non-small-cell lung carcinoma
Chemotherapy
Oncology
Raja M. Flores
Nicholas J. Vogelzang
Medicine
Cancer treatments
Lung cancer

DECISION AID TOOL STAGE IB Non-Small Cell Lung Cancer (NSCLC) Cisplatin plus Vinorelbine Chemotherapy after Surgery This is a DECISION AID TOOL for patients who have had surgery to remove non-small cell lung cancer, and

Add to Reading List

Source URL: www.asco.org

Download Document from Source Website

File Size: 93,80 KB

Share Document on Facebook

Similar Documents

Clinical Neutron Therapy System Reference Manual Jonathan Jacky1 Ruedi Risler Radiation Oncology, Box

Clinical Neutron Therapy System Reference Manual Jonathan Jacky1 Ruedi Risler Radiation Oncology, Box

DocID: 1xVse - View Document

Formal Development of a Graphical User Interface for a Radiation Therapy Machine Jonathan Jacky  Jonathan Unger Radiation Oncology Department RC-08 University of Washington

Formal Development of a Graphical User Interface for a Radiation Therapy Machine Jonathan Jacky  Jonathan Unger Radiation Oncology Department RC-08 University of Washington

DocID: 1xViy - View Document

Experience with Z Developing a Control Program for a Radiation Therapy Machine Jonathan Jacky , Jonathan Unger, Michael Patrick and Ruedi Risler Radiation Oncology Box

Experience with Z Developing a Control Program for a Radiation Therapy Machine Jonathan Jacky , Jonathan Unger, Michael Patrick and Ruedi Risler Radiation Oncology Box

DocID: 1xV2d - View Document

Formal Specication and Development of Control System Input/Output Jonathan Jacky Radiation Oncology Department RC-08 University of Washington

Formal Speci cation and Development of Control System Input/Output Jonathan Jacky Radiation Oncology Department RC-08 University of Washington

DocID: 1xUvZ - View Document

European Society for Medical Oncology (ESMOCongress Roche Analyst Audio Webcast Monday, 22 October 2018 Welcome Daniel O’Day, CEO Roche Pharmaceuticals

European Society for Medical Oncology (ESMOCongress Roche Analyst Audio Webcast Monday, 22 October 2018 Welcome Daniel O’Day, CEO Roche Pharmaceuticals

DocID: 1xTgE - View Document